OverviewChartTechnicalNewsTraderScreen

Intra Cellular Therapies Inc/  US46116X1019  /

NASDAQ
17/05/2024  22:00:00 Chg. -1.5300 Volume Bid23:17:08 Ask23:17:08 High Low
65.0000USD -2.30% 783,425
Turnover: 32.23 mill.		 65.0000Bid Size: 100 75.0000Ask Size: 100 66.8800 64.9200
GlobeNewswire 08/05 Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
GlobeNewswire 07/05 Intra-Cellular Therapies Reports First Quarter 2024 Financial Results
GlobeNewswire 30/04 Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
GlobeNewswire 24/04 Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise o...
GlobeNewswire 18/04 Intra-Cellular Therapies Prices Public Offering of Common Stock
GlobeNewswire 16/04 Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
GlobeNewswire 16/04 Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumate...
GlobeNewswire 19/03 Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
GlobeNewswire 06/03 Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
GlobeNewswire 27/02 Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
GlobeNewswire 22/02 Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Co...
GlobeNewswire 08/02 Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call...
GlobeNewswire 02/01 Intra-Cellular Therapies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 05/12/2023 Intra-Cellular Therapies Highlights Data Presentations at the American College of Neuropsychopharmac...
GlobeNewswire 15/11/2023 Intra-Cellular Therapies to Present at the 6th Annual Evercore ISI HealthCONx Conference
GlobeNewswire 02/11/2023 Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales ...
GlobeNewswire 31/10/2023 Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
GlobeNewswire 26/10/2023 Intra-Cellular Therapies to Host Third Quarter 2023 Financial Results Conference Call and Webcast
GlobeNewswire 20/09/2023 Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire 11/09/2023 Intra-Cellular Therapies Announces Presentations at Psych Congress 2023 Including Positive Results f...
GlobeNewswire 05/09/2023 Intra-Cellular Therapies to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
GlobeNewswire 01/03/2022 Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Co...
GlobeNewswire 22/02/2022 Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call...
GlobeNewswire 07/01/2022 Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise o...
GlobeNewswire 05/01/2022 Intra-Cellular Therapies Prices Public Offering of Common Stock